Music with auditory beats was linked to a bigger cortisol drop than pink noise in one small trial

What happened

Personalized music paired with auditory beat stimulation (ABS) was reported to lower the stress hormone cortisol more than twice as much as pink noise in a randomized trial of 83 students, as first reported by Medical Xpress (Medical Xpress).

That is a real, interesting result. It is also an early one. We could not read the full paper, so everything below comes from the news summary and the team's earlier published work.

What the trial reportedly found

• Participants heard 24 minutes of personalized music with ABS or 24 minutes of pink noise matched for volume.
• The music was tailored to each person's starting mood, then adjusted toward a calmer state.
• The report says cortisol fell more than twice as much after the music-with-ABS session as after pink noise.
• The summary reports that brain activity linked to emotional regulation moved in opposite directions: slightly up after music, down after pink noise.

The summary we worked from also says participants felt equally calm after both conditions. We could not confirm that in the text we could access. If it holds, the benefit showed up on a biomarker but not in how people felt.

The design is likely the one in a registered protocol (also on ClinicalTrials.gov), though we haven't confirmed the link. It describes a two-arm randomized trial of a single session. The abstract planned 50 Canadian undergraduates who report anxiety. The published enrollment is 83, and we don't know why.

Planned outcomes included salivary cortisol, heart rate variability, EEG and self-reported anxiety. Cortisol was a pre-specified hypothesis. Participants had to be 18 to 30 with a score of at least 1 on the GAD-2 anxiety screen. People with cardiac issues or a history of seizures were excluded.

What it does not show

• Size of the effect. The report gives no absolute cortisol values, confidence intervals or effect size, so a doubling of a small change is still small.
• Anything beyond one session. Nothing we read shows lasting effects or clinical benefit.
• Relevance to the general public. The likely sample is young students with at least mild anxiety.
• Clean blinding. Participants may be able to tell music from pink noise. We don't know how the paper handles that, though the main outcome is a biomarker rather than self-report.
• A match with how people felt. Equal reported calm would sit oddly with the group's earlier self-report findings, and it's a fair question for the authors.

What it means for you

Don't buy anything on the strength of this one result. A cortisol change after a single lab session doesn't tell you whether your daily stress will ease.

The "low-cost" part of the pitch is also unsupported. The tested product is proprietary, we found no pricing, and nothing shows that a regular playlist or free track does the same thing.

If you already use music to wind down, there is no reason to stop. Just treat it as a pleasant habit, not a proven treatment. If anxiety is persistent or getting in the way of your life, talk to a clinician.

Context: the same group, a growing pile of mostly self-reported data

This is the group's first biomarker test. Earlier trials relied on self-reported anxiety and came from the team that developed the product, so they are not independent replication.

Russo called about 24 minutes the "sweet spot" (Medical Xpress). The dose-response study also assumed a large combined effect (Cohen's d of 0.80) drawn from the group's earlier work. That is a generous assumption, and it isn't independent data.

The next steps are clear: the full paper, the absolute numbers, the conflict statement and a replication by a team with no stake in the product.